ATE247465T1 - Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten - Google Patents

Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten

Info

Publication number
ATE247465T1
ATE247465T1 AT00902404T AT00902404T ATE247465T1 AT E247465 T1 ATE247465 T1 AT E247465T1 AT 00902404 T AT00902404 T AT 00902404T AT 00902404 T AT00902404 T AT 00902404T AT E247465 T1 ATE247465 T1 AT E247465T1
Authority
AT
Austria
Prior art keywords
administration
water
medicinal products
paclitaxel derivatives
insoluble paclitaxel
Prior art date
Application number
AT00902404T
Other languages
English (en)
Inventor
Angelica Alvarado
Robert Eury
Irina D Pomerantseva
Michael Froix
Original Assignee
Quanam Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quanam Medical Corp filed Critical Quanam Medical Corp
Application granted granted Critical
Publication of ATE247465T1 publication Critical patent/ATE247465T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Nanotechnology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
AT00902404T 1999-01-12 2000-01-12 Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten ATE247465T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11560999P 1999-01-12 1999-01-12
US33544299A 1999-06-17 1999-06-17
PCT/US2000/000832 WO2000041687A2 (en) 1999-01-12 2000-01-12 Composition and methods for administration of water-insoluble paclitaxel derivatives

Publications (1)

Publication Number Publication Date
ATE247465T1 true ATE247465T1 (de) 2003-09-15

Family

ID=26813385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902404T ATE247465T1 (de) 1999-01-12 2000-01-12 Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten

Country Status (7)

Country Link
EP (1) EP1143968B9 (de)
JP (1) JP2002534461A (de)
AT (1) ATE247465T1 (de)
AU (1) AU775875B2 (de)
CA (1) CA2358638A1 (de)
DE (1) DE60004630T2 (de)
WO (1) WO2000041687A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333347B1 (en) 1999-01-29 2001-12-25 Angiotech Pharmaceuticals & Advanced Research Tech Intrapericardial delivery of anti-microtubule agents
US7225143B1 (en) 1999-04-30 2007-05-29 Concept Shopping, Inc. System and method for inverted promotions
EP2918296A1 (de) 2003-02-28 2015-09-16 Biointeractions Ltd. Polymernetzwerksystem für medizinische Vorrichtungen und Verfahren zur Verwendung
US20060013853A1 (en) * 2004-07-19 2006-01-19 Richard Robert E Medical devices having conductive substrate and covalently bonded coating layer
JP2008519076A (ja) * 2004-11-02 2008-06-05 テルアビブ ユニバーシティ フューチャー テクノロジー デベロップメント エル．ピー． 脂質化グリコサミノグリカン粒子中の水不溶性又は水難溶性薬物の処方、並びに診断及び治療のためのこれらの使用
DE602006018744D1 (de) 2005-06-23 2011-01-20 Keygene Nv Strategien mit hohem durchsatz zur identifizierung und zum nachweis von polymorphismen
US20090170713A1 (en) 2005-09-29 2009-07-02 Keygene N.V. High throughput screening of mutagenized populations
ES2558124T3 (es) 2005-12-22 2016-02-02 Keygene N.V. Procedimiento para detección de polimorfismos basada en AFLP de alto rendimiento
US20070298069A1 (en) * 2006-06-26 2007-12-27 Boston Scientific Scimed, Inc. Medical devices for release of low solubility therapeutic agents
US20080181928A1 (en) * 2006-12-22 2008-07-31 Miv Therapeutics, Inc. Coatings for implantable medical devices for liposome delivery
US10806830B2 (en) 2012-10-26 2020-10-20 Urotronic, Inc. Drug-coated balloon catheters for body lumens
WO2020172560A1 (en) 2019-02-22 2020-08-27 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11938287B2 (en) 2012-10-26 2024-03-26 Urotronic, Inc. Drug-coated balloon catheters for body lumens
JP2015536709A (ja) 2012-10-26 2015-12-24 ウロトロニック・インコーポレイテッドＵｒｏｔｒｏｎｉｃ， Ｉｎｃ． 非血管狭窄のための薬物被覆バルーンカテーテル
US11504450B2 (en) 2012-10-26 2022-11-22 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10898700B2 (en) 2012-10-26 2021-01-26 Urotronic, Inc. Balloon catheters for body lumens
US10850076B2 (en) 2012-10-26 2020-12-01 Urotronic, Inc. Balloon catheters for body lumens
US10881839B2 (en) 2012-10-26 2021-01-05 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11904072B2 (en) 2015-04-24 2024-02-20 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US10888640B2 (en) 2015-04-24 2021-01-12 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
EP4106828B1 (de) 2020-02-21 2026-03-11 Tonic Medical, Inc. Polymerverkapselte wirkstoffpartikel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5163952A (en) * 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US5721268A (en) * 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
PT1118325E (pt) * 1993-07-29 2006-05-31 Us Health Utilizacao de paclitaxel e seus derivados na preparacao de um medicamento para o tratamento de restenose
US5603722A (en) * 1995-06-06 1997-02-18 Quanam Medical Corporation Intravascular stent
JP4192208B2 (ja) * 1995-09-12 2008-12-10 セファロン リミテッド 加水分解促進性のタキサン疎水性誘導体
US5977163A (en) * 1996-03-12 1999-11-02 Pg-Txl Company, L. P. Water soluble paclitaxel prodrugs
WO1997045105A1 (en) * 1996-05-24 1997-12-04 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing diseases of body passageways
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same

Also Published As

Publication number Publication date
EP1143968B1 (de) 2003-08-20
CA2358638A1 (en) 2000-07-20
WO2000041687A2 (en) 2000-07-20
EP1143968A2 (de) 2001-10-17
JP2002534461A (ja) 2002-10-15
AU775875B2 (en) 2004-08-19
DE60004630T2 (de) 2004-06-17
WO2000041687A3 (en) 2000-11-30
EP1143968B9 (de) 2004-08-04
AU2412700A (en) 2000-08-01
DE60004630D1 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
ATE247465T1 (de) Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten
FI964583A0 (fi) Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
DE69433381D1 (de) Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
TJ275B (en) Derivatives of cyclodextrins exhibiting enhenced aqueous solubility and the use thereof
UY27273A1 (es) Solución oral de arilpiprazol
DK0767800T3 (da) Histidin- og homohistidinderivater som inhibitorer af protein farnesyltransferase
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20063667L (no) Anvendelse av et anti-mikrotubulimiddel for fremstilling av en farmasoytisk blanding for behandling eller forhindring av kirurgiske adhesjoner
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
TR200200821T2 (tr) 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı.
DE60030124D1 (de) Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
FI102475B1 (fi) Menetelmä farmaseuttisesti aktiivisten oktahydro- ja heksahydrobentso[f]kinolinonijohdannaisten valmistamiseksi
TR200001147T2 (tr) Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
DE69941966D1 (de) Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
DE58904722D1 (de) Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden
ATE274487T1 (de) Verfahren zur gleichzeitigen herstellung von maleinsäureanhydrid und seinen hydrogenierten derivaten
ATE131725T1 (de) Formulierungen zur behandlung der vaginalen trockenheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties